Home

JAMES R MCNAB

CIK 1190126 · last filed 2022-01-28

JAMES R MCNAB is a corporate insider who has filed 37 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for TTNP, was dated Jan 28, 2022. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.4K

Companies

2

Total Filings

37

Lifetime Open-Market Net

-$3.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TITAN PHARMACEUTICALS INC (TTNP) Delisted Director 2,634 $4.61 $12.1K $242.3K 9 2022-01-28
CRIS Director 488 $4.83 $2.4K -$3.29M 27 2017-05-05

Recent Filings

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-01-28 TITAN PHARMACEUTICALS INC (TTNP) Delisted Other (J) +51,021 $0 EDGAR
2022-01-05 TITAN PHARMACEUTICALS INC (TTNP) Delisted Grant (A) — $0 EDGAR
2021-02-11 TITAN PHARMACEUTICALS INC (TTNP) Delisted Grant (A) — $0 EDGAR
2018-09-25 TITAN PHARMACEUTICALS INC (TTNP) Delisted Mixed +200,000 $50.0K EDGAR
2017-09-19 TITAN PHARMACEUTICALS INC (TTNP) Delisted Grant (A) — $0 EDGAR
2017-05-05 CRIS Sell (S) −76,276 -$155.4K EDGAR
2017-05-05 CRIS Sell (S) −76,276 -$155.4K EDGAR
2017-05-02 CRIS Sell (S) −116,708 -$278.0K EDGAR
2017-04-27 CRIS Sell (S) −146,694 -$383.0K EDGAR
2017-04-27 CRIS Sell (S) −110,322 -$285.7K EDGAR
Showing 1–10 of 37
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.